Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02190669 · ClinicalTrials.gov registry record

Exercise and Diabetes - an Observational Study of Exercise and Blood Glucose Control

A clinical trial of Type 2 Diabetes and Type 1 Diabetes, sponsored by Sansum Diabetes Research Institute.

Completed
Registry status
12
Enrollment target
1
Study location

NCT02190669: Completed study of Type 2 Diabetes and Type 1 Diabetes, sponsored by Sansum Diabetes Research Institute.

NCT02190669 is a study of Type 2 Diabetes and Type 1 Diabetes that has completed, run by Sansum Diabetes Research Institute. The registered enrollment target is 12 participants, below the 3,924-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02190669, a study of Type 2 Diabetes and Type 1 Diabetes, has completed, sponsored by Sansum Diabetes Research Institute.

COMPLETED
Registry status
12 participants
Enrollment target
1
Study location

Study Summary

This proposal seeks to gather continuous blood glucose and physical activity data from individuals with and without diabetes.

Interventions

  • OTHER exercise

Study Locations (1)

California

  • Sansum Diabetes Research Institute - Santa Barbara

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2014-06
Est. Completion 2014-07
Sansum Diabetes Research Institute

33 total trials

What the finished NCT02190669 record still lists

NCT02190669 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 3,924-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (100% lower).

The record links to 2 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which exercise is the first listed.

NCT02190669 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT02190669 about?

NCT02190669 is a clinical study titled "Exercise and Diabetes - an Observational Study of Exercise and Blood Glucose Control". This proposal seeks to gather continuous blood glucose and physical activity data from individuals with and without diabetes.

What is the current status of trial NCT02190669?

This trial is currently completed. The enrollment target is 12 participants. The study started on 2014-06. Estimated completion is 2014-07.

What conditions does trial NCT02190669 study?

This clinical trial studies the following conditions: Type 2 Diabetes, Type 1 Diabetes.

What interventions are being tested in trial NCT02190669?

The interventions under investigation include: exercise (OTHER).

Who is sponsoring clinical trial NCT02190669?

This trial is sponsored by Sansum Diabetes Research Institute, which has 33 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02190669 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02190669's enrollment target sits among peer trials

12 314th of 327 higher than 9 of 327 other Type 2 Diabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Type 2 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02190669, the US trial registry maintained by the National Library of Medicine. NCT02190669 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.